C2N Diagnostics, LLC
C2N Diagnostics, LLC, headquartered in the United States, is a pioneering company in the field of diagnostic testing, particularly focused on neurodegenerative diseases. Founded in 2012, C2N has established itself as a leader in the development of innovative biomarkers that aid in the early detection and management of conditions such as Alzheimer’s disease. The company’s flagship products, including the PrecivityAD™ test, are designed to provide clinicians with critical insights into patients' cognitive health, setting C2N apart in the competitive diagnostics landscape. With a commitment to advancing precision medicine, C2N Diagnostics has achieved significant milestones, including partnerships with leading research institutions and recognition for its contributions to the field. As a trusted name in neurodiagnostics, C2N continues to enhance patient care through its cutting-edge solutions.
DitchCarbon Score
How does C2N Diagnostics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
C2N Diagnostics, LLC's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
C2N Diagnostics, LLC's reported carbon emissions
C2N Diagnostics, LLC, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or commitments outlined in their climate initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate a need for further transparency in their environmental impact and sustainability efforts. As the industry increasingly prioritises climate commitments, C2N Diagnostics may benefit from establishing clear targets and reporting mechanisms to align with best practices in carbon management.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
C2N Diagnostics, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
